SlideShare a Scribd company logo
jul /11 /16
Congestive Heart Failure
Manuel Fonseca Crescioni
Medical intern
Hospital San Lucas Guayama P.R
✤ IN USA CHF is the MCC of being admitted to the
hospital
Heart Failure
✤Dysfunction of the heart as a pump
✤Results in insufficient 02 delivery to tissues
acompanied by the accumulation of fluid in the lungs
Pathophysiology
✤ Activation of renin-angiotensin system
✤ Angiotensin II( TPR, Aldosterone)
✤Can be either from systolic dysfunction( decreased
EF and heart dilatation) or from diastolic dysfunction (
inability to relax and recieve blood, EF is preserved
sometimes even above normal)
Causes of Systolic Heart Failure
✤ HTN (MC)
✤ MI
✤ Valvular heart dz of all types
✤ All 3 account for the vast
majority of cases (over 95%)
Systolic Heart Failure
✤ Less common causes of systolic dysfunction are;
✤ Etoh
✤ Postviral (idiodpathic) myocarditis = Often due to coxsackie B virus
✤ Radiation
✤ Adriamycin(doxorubicin)
✤ Chagas
✤ Hemochromatosis
✤ Thyroid dz
✤ Peripartum cardiomyopathy
✤ Thiamine deficiency
Presentation
✤ Dyspnea (SOB)
✤ Orthopnea(worse when lying flat, relieved when sitting up
or standing)
✤ Rales , Wheezing on lung examination Bibasilar crakles,
decreased breath sounds at the bases due to pleura
effusion
✤ JVD
✤ S3, S4
Diagnostic Test
✤ Echocardiography (To distinguish systolic from
diastolic dusfunction) every pt must get echo to
evaluate EF
✤ Best initial test= Transthoracic echo
✤ Most accurate test= MUGA Scan , Nuclear
Ventriculogram,
✤ BNP
Systolic Dysfunction (low EF) Tx.
✤ ACE inhibitors , ARB*
✤ B-blockers*
✤ Spirinolactone/eplerenone*
✤ Hydralazine/ nitrates*
✤ Diuretics
✤ Digoxin (does not lower mortality in CHF, controls sx.)
✤ Implantable defibrillator*/ Biventricular pacemaker*( EF below 35%)
✤ Transplantation when all else fails
Distolic Dysfunction (CHF w/
Preserved EF ) Tx.
✤ Nothing we know lowers mortality in diastolic
dysfunction
✤ Clearly beneficial= B-Blockers and Diuretics
✤ Clearly not Beneficial Digoxin and Spirinolactone
✤ Uncertain = ACE inhib, ARB’s & hydralazine
References
✤ Harrisons Principles of Internal Medicine 15th
Eugene Braunwald
✤ Medscape
✤ New York Heart Association
✤ Fundamental of Pathology Husain A. Sattar
✤ Master The Boards Step 2 CK Conrad Fischer, MD
CHF Hosp. San Lucas interno new

More Related Content

What's hot

Restrictive cardiomyopathy
Restrictive cardiomyopathyRestrictive cardiomyopathy
Restrictive cardiomyopathy
Johnson Velukkaran
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
Shybin Usman
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
rod prasad
 
dilated cardiomyopathy
dilated cardiomyopathydilated cardiomyopathy
dilated cardiomyopathy
joselinejona
 
Cardiomyopathies
CardiomyopathiesCardiomyopathies
Cardiomyopathies
Sachin Adukia
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
Anvin Thomas
 
Case Study Hypertrophic Cardiomyopathy
Case Study  Hypertrophic CardiomyopathyCase Study  Hypertrophic Cardiomyopathy
Case Study Hypertrophic Cardiomyopathy
jmlafroscia
 
6 cardiomyopathies
6 cardiomyopathies6 cardiomyopathies
6 cardiomyopathies
Engidaw Ambelu
 
Cardiomyopathies
CardiomyopathiesCardiomyopathies
Cardiomyopathies
Dr.Partho Das
 
cardiomyopathy
cardiomyopathycardiomyopathy
cardiomyopathy
Praveen Nagula
 
Mycardial infraction.ppt
Mycardial infraction.pptMycardial infraction.ppt
Mycardial infraction.ppt
Krishna Kumar
 
Pharmacotherapy of ischemic heart disease
Pharmacotherapy of ischemic heart diseasePharmacotherapy of ischemic heart disease
Pharmacotherapy of ischemic heart disease
tolcha regasa
 
Ischemic Heart Disease Surgery
Ischemic Heart Disease SurgeryIschemic Heart Disease Surgery
Ischemic Heart Disease Surgery
Hamza AlGhamdi
 
myocardial infaction etiology and pathogenisis by Dr Harikrishna S
myocardial infaction etiology and pathogenisis  by Dr Harikrishna Smyocardial infaction etiology and pathogenisis  by Dr Harikrishna S
myocardial infaction etiology and pathogenisis by Dr Harikrishna S
Dr Harikrishna Harindran
 
Restrictive cardiomyopathy
Restrictive cardiomyopathyRestrictive cardiomyopathy
Restrictive cardiomyopathy
Nizam Uddin
 
Cardiomyopathies
CardiomyopathiesCardiomyopathies
Cardiomyopathies
Azad Haleem
 
hypertrophic cardiomyopathy-a case report
hypertrophic cardiomyopathy-a case reporthypertrophic cardiomyopathy-a case report
hypertrophic cardiomyopathy-a case report
Debarshee Chakraborty
 
Case presentation controversies in Cardiomyopathy
Case presentation controversies in CardiomyopathyCase presentation controversies in Cardiomyopathy
Case presentation controversies in Cardiomyopathy
drucsamal
 
An unusual aspect of hypertrophic cardiomyopathy
An unusual aspect of hypertrophic cardiomyopathyAn unusual aspect of hypertrophic cardiomyopathy
An unusual aspect of hypertrophic cardiomyopathy
drucsamal
 
Acute coronary syndrome
Acute coronary syndrome Acute coronary syndrome
Acute coronary syndrome
Sithu Bala ( Dr )
 

What's hot (20)

Restrictive cardiomyopathy
Restrictive cardiomyopathyRestrictive cardiomyopathy
Restrictive cardiomyopathy
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
 
dilated cardiomyopathy
dilated cardiomyopathydilated cardiomyopathy
dilated cardiomyopathy
 
Cardiomyopathies
CardiomyopathiesCardiomyopathies
Cardiomyopathies
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
 
Case Study Hypertrophic Cardiomyopathy
Case Study  Hypertrophic CardiomyopathyCase Study  Hypertrophic Cardiomyopathy
Case Study Hypertrophic Cardiomyopathy
 
6 cardiomyopathies
6 cardiomyopathies6 cardiomyopathies
6 cardiomyopathies
 
Cardiomyopathies
CardiomyopathiesCardiomyopathies
Cardiomyopathies
 
cardiomyopathy
cardiomyopathycardiomyopathy
cardiomyopathy
 
Mycardial infraction.ppt
Mycardial infraction.pptMycardial infraction.ppt
Mycardial infraction.ppt
 
Pharmacotherapy of ischemic heart disease
Pharmacotherapy of ischemic heart diseasePharmacotherapy of ischemic heart disease
Pharmacotherapy of ischemic heart disease
 
Ischemic Heart Disease Surgery
Ischemic Heart Disease SurgeryIschemic Heart Disease Surgery
Ischemic Heart Disease Surgery
 
myocardial infaction etiology and pathogenisis by Dr Harikrishna S
myocardial infaction etiology and pathogenisis  by Dr Harikrishna Smyocardial infaction etiology and pathogenisis  by Dr Harikrishna S
myocardial infaction etiology and pathogenisis by Dr Harikrishna S
 
Restrictive cardiomyopathy
Restrictive cardiomyopathyRestrictive cardiomyopathy
Restrictive cardiomyopathy
 
Cardiomyopathies
CardiomyopathiesCardiomyopathies
Cardiomyopathies
 
hypertrophic cardiomyopathy-a case report
hypertrophic cardiomyopathy-a case reporthypertrophic cardiomyopathy-a case report
hypertrophic cardiomyopathy-a case report
 
Case presentation controversies in Cardiomyopathy
Case presentation controversies in CardiomyopathyCase presentation controversies in Cardiomyopathy
Case presentation controversies in Cardiomyopathy
 
An unusual aspect of hypertrophic cardiomyopathy
An unusual aspect of hypertrophic cardiomyopathyAn unusual aspect of hypertrophic cardiomyopathy
An unusual aspect of hypertrophic cardiomyopathy
 
Acute coronary syndrome
Acute coronary syndrome Acute coronary syndrome
Acute coronary syndrome
 

Similar to CHF Hosp. San Lucas interno new

Pericardial effusion final
Pericardial effusion finalPericardial effusion final
Pericardial effusion final
Kefelegn Tadesse
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failure
Lih Yin Chong
 
takotsubo cardiomyopathy/ Broken Heart Syndrome
takotsubo cardiomyopathy/ Broken Heart Syndrometakotsubo cardiomyopathy/ Broken Heart Syndrome
takotsubo cardiomyopathy/ Broken Heart Syndrome
Dr. Mohammad Abas Reshi
 
Broken heart syndrome. Diagnostics
Broken heart syndrome. DiagnosticsBroken heart syndrome. Diagnostics
Broken heart syndrome. Diagnostics
Joisy Aloor
 
3. Acute coronary syndrome.pptx
3. Acute coronary syndrome.pptx3. Acute coronary syndrome.pptx
3. Acute coronary syndrome.pptx
Parbati Dahal
 
7 ihd (2)
7 ihd (2)7 ihd (2)
7 ihd (2)
Engidaw Ambelu
 
Stroke
StrokeStroke
ischemic heart disease
ischemic heart diseaseischemic heart disease
ischemic heart diseasemayumi hosoya
 
Cardiac emergencies
Cardiac emergenciesCardiac emergencies
Cardiac emergencies
Prof Vijayraddi
 
Cardiology 4.6. Hypertrophic Cardiomyopathy HCM - Dr. Farjad Ikram
Cardiology 4.6. Hypertrophic Cardiomyopathy HCM - Dr. Farjad IkramCardiology 4.6. Hypertrophic Cardiomyopathy HCM - Dr. Farjad Ikram
Cardiology 4.6. Hypertrophic Cardiomyopathy HCM - Dr. Farjad Ikram
Farjad Ikram
 
Clinical features & Diagnosis of Pulmonary Vascular Diseases
Clinical features & Diagnosis of Pulmonary Vascular DiseasesClinical features & Diagnosis of Pulmonary Vascular Diseases
Clinical features & Diagnosis of Pulmonary Vascular Diseases
Bala Murugan
 
Cardiomyopathy Presentation
Cardiomyopathy PresentationCardiomyopathy Presentation
Cardiomyopathy Presentation
Paul Pasco
 
Cardiogenic shock and IABP.pptx
Cardiogenic shock and IABP.pptxCardiogenic shock and IABP.pptx
Cardiogenic shock and IABP.pptx
PRIYANKA BHATI
 
myocardial infarction
myocardial infarction myocardial infarction
myocardial infarction
Sam Mathew
 
power point myocardial infaction
power point myocardial infaction power point myocardial infaction
power point myocardial infaction
mohammadnujedat1
 
Ac Coronary Syndrome
Ac Coronary SyndromeAc Coronary Syndrome
Ac Coronary Syndromevineet malik
 
Takotsubo Cardiomyopathy - Rivin
Takotsubo Cardiomyopathy  - RivinTakotsubo Cardiomyopathy  - Rivin
Takotsubo Cardiomyopathy - Rivin
Rivindu Wickramanayake
 
229814.ppt
229814.ppt229814.ppt
229814.ppt
BuzzTera
 
Cardiovascular diseases modified
Cardiovascular diseases modifiedCardiovascular diseases modified
Cardiovascular diseases modifiedxtrm nurse
 
Ischemic heart disease
Ischemic heart diseaseIschemic heart disease
Ischemic heart disease
hus100
 

Similar to CHF Hosp. San Lucas interno new (20)

Pericardial effusion final
Pericardial effusion finalPericardial effusion final
Pericardial effusion final
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failure
 
takotsubo cardiomyopathy/ Broken Heart Syndrome
takotsubo cardiomyopathy/ Broken Heart Syndrometakotsubo cardiomyopathy/ Broken Heart Syndrome
takotsubo cardiomyopathy/ Broken Heart Syndrome
 
Broken heart syndrome. Diagnostics
Broken heart syndrome. DiagnosticsBroken heart syndrome. Diagnostics
Broken heart syndrome. Diagnostics
 
3. Acute coronary syndrome.pptx
3. Acute coronary syndrome.pptx3. Acute coronary syndrome.pptx
3. Acute coronary syndrome.pptx
 
7 ihd (2)
7 ihd (2)7 ihd (2)
7 ihd (2)
 
Stroke
StrokeStroke
Stroke
 
ischemic heart disease
ischemic heart diseaseischemic heart disease
ischemic heart disease
 
Cardiac emergencies
Cardiac emergenciesCardiac emergencies
Cardiac emergencies
 
Cardiology 4.6. Hypertrophic Cardiomyopathy HCM - Dr. Farjad Ikram
Cardiology 4.6. Hypertrophic Cardiomyopathy HCM - Dr. Farjad IkramCardiology 4.6. Hypertrophic Cardiomyopathy HCM - Dr. Farjad Ikram
Cardiology 4.6. Hypertrophic Cardiomyopathy HCM - Dr. Farjad Ikram
 
Clinical features & Diagnosis of Pulmonary Vascular Diseases
Clinical features & Diagnosis of Pulmonary Vascular DiseasesClinical features & Diagnosis of Pulmonary Vascular Diseases
Clinical features & Diagnosis of Pulmonary Vascular Diseases
 
Cardiomyopathy Presentation
Cardiomyopathy PresentationCardiomyopathy Presentation
Cardiomyopathy Presentation
 
Cardiogenic shock and IABP.pptx
Cardiogenic shock and IABP.pptxCardiogenic shock and IABP.pptx
Cardiogenic shock and IABP.pptx
 
myocardial infarction
myocardial infarction myocardial infarction
myocardial infarction
 
power point myocardial infaction
power point myocardial infaction power point myocardial infaction
power point myocardial infaction
 
Ac Coronary Syndrome
Ac Coronary SyndromeAc Coronary Syndrome
Ac Coronary Syndrome
 
Takotsubo Cardiomyopathy - Rivin
Takotsubo Cardiomyopathy  - RivinTakotsubo Cardiomyopathy  - Rivin
Takotsubo Cardiomyopathy - Rivin
 
229814.ppt
229814.ppt229814.ppt
229814.ppt
 
Cardiovascular diseases modified
Cardiovascular diseases modifiedCardiovascular diseases modified
Cardiovascular diseases modified
 
Ischemic heart disease
Ischemic heart diseaseIschemic heart disease
Ischemic heart disease
 

CHF Hosp. San Lucas interno new

  • 1. jul /11 /16 Congestive Heart Failure Manuel Fonseca Crescioni Medical intern Hospital San Lucas Guayama P.R
  • 2. ✤ IN USA CHF is the MCC of being admitted to the hospital
  • 3. Heart Failure ✤Dysfunction of the heart as a pump ✤Results in insufficient 02 delivery to tissues acompanied by the accumulation of fluid in the lungs
  • 4. Pathophysiology ✤ Activation of renin-angiotensin system ✤ Angiotensin II( TPR, Aldosterone)
  • 5. ✤Can be either from systolic dysfunction( decreased EF and heart dilatation) or from diastolic dysfunction ( inability to relax and recieve blood, EF is preserved sometimes even above normal)
  • 6. Causes of Systolic Heart Failure ✤ HTN (MC) ✤ MI ✤ Valvular heart dz of all types ✤ All 3 account for the vast majority of cases (over 95%)
  • 7. Systolic Heart Failure ✤ Less common causes of systolic dysfunction are; ✤ Etoh ✤ Postviral (idiodpathic) myocarditis = Often due to coxsackie B virus ✤ Radiation ✤ Adriamycin(doxorubicin) ✤ Chagas ✤ Hemochromatosis ✤ Thyroid dz ✤ Peripartum cardiomyopathy ✤ Thiamine deficiency
  • 8. Presentation ✤ Dyspnea (SOB) ✤ Orthopnea(worse when lying flat, relieved when sitting up or standing) ✤ Rales , Wheezing on lung examination Bibasilar crakles, decreased breath sounds at the bases due to pleura effusion ✤ JVD ✤ S3, S4
  • 9. Diagnostic Test ✤ Echocardiography (To distinguish systolic from diastolic dusfunction) every pt must get echo to evaluate EF ✤ Best initial test= Transthoracic echo ✤ Most accurate test= MUGA Scan , Nuclear Ventriculogram, ✤ BNP
  • 10.
  • 11.
  • 12.
  • 13. Systolic Dysfunction (low EF) Tx. ✤ ACE inhibitors , ARB* ✤ B-blockers* ✤ Spirinolactone/eplerenone* ✤ Hydralazine/ nitrates* ✤ Diuretics ✤ Digoxin (does not lower mortality in CHF, controls sx.) ✤ Implantable defibrillator*/ Biventricular pacemaker*( EF below 35%) ✤ Transplantation when all else fails
  • 14. Distolic Dysfunction (CHF w/ Preserved EF ) Tx. ✤ Nothing we know lowers mortality in diastolic dysfunction ✤ Clearly beneficial= B-Blockers and Diuretics ✤ Clearly not Beneficial Digoxin and Spirinolactone ✤ Uncertain = ACE inhib, ARB’s & hydralazine
  • 15. References ✤ Harrisons Principles of Internal Medicine 15th Eugene Braunwald ✤ Medscape ✤ New York Heart Association ✤ Fundamental of Pathology Husain A. Sattar ✤ Master The Boards Step 2 CK Conrad Fischer, MD